The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells

The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells

Bibliographic Details
Main Authors:	G. Sampey, D. Irlbeck, E. Browne, M. Kanke, E. Cule, S. Wills, S. Falcinelli, Z. Wang, J. Kircherr, B. Allard, E. Stuelke, K. Sholtis, R. Ferris, J. Brehm, D. Favre, J.-P. Routy, C. Jones, N. Archin, D. Margolis, R. Dunham
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020310475

Similar Items

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
by: A.A. Okoye, et al.
Published: (2019-12-01)

The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion
by: M. Mavigner, et al.
Published: (2019-12-01)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017-12-01)

SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway
by: G.C. Sampey, et al.
Published: (2017-12-01)

Enhanced chemotherapy activity of AZD5582 and SM164 encapsulated in rabies virus glycoprotein-liposomes to downregulate the expression of inhibitor of apoptosis proteins in glioblastoma
by: LI, YIN-RONG, et al.
Published: (2018)

A modified viral outgrowth assay incorporating ultra-sensitive P24 measurements
by: N. Archin, et al.
Published: (2017-12-01)

Evaluation of IAP/SMAC mimetics as latency reversal agents in primary cells and cytokine induction in in vivo models predictive of cytokine release
by: B. Howell, et al.
Published: (2019-12-01)

Protein crotonylation sensitizes SMACm disruption of latent HIV by modulating the ncNF-κB signaling pathway at the step of p100 cleavage into p52
by: J. Guochun, et al.
Published: (2019-12-01)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

New Frontiers in Measuring and Characterizing the HIV Reservoir
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Role of Smac/DIABLO in cancer progression
by: Melendez-Zajgla Jorge, et al.
Published: (2008-09-01)

Future Therapeutic Directions for Smac-Mimetics
by: Emma Morrish, et al.
Published: (2020-02-01)

Applied of the SMAC Method to Undergate Flows
by: Huey-Hong Hsieh, et al.
Published: (1995)

The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection
by: C. Gay, et al.
Published: (2019-07-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer
by: Bozena Dobrzycka, et al.
Published: (2010-04-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
by: Magdalena Garbowicz, et al.
Published: (2011-04-01)

Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance
by: Weike Li, et al.
Published: (2019-09-01)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015-12-01)

Synergistic effects of combining PARP inhibitor (AZD2281) and ATR inhibitor (AZD6738) in Ewing Sarcoma cell lines
by: Meyer, Stephanie C.
Published: (2018)

An exploration of novel physiological roles for Smac/DIABLO
by: Higgins, Julia
Published: (2012)

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
by: Schwarz Margaret A, et al.
Published: (2011-01-01)

The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
by: Huang Q, et al.
Published: (2019-04-01)

A case report of toxic epidermal necrolysis associated with AZD-9291
by: Wang J, et al.
Published: (2018-07-01)

Smac-mimetics reduce numbers and viability of human osteoclasts
by: Ingrid Nyhus Moen, et al.
Published: (2021-02-01)

User Interface for the SMAC Traffic Accident Reconstruction Program
by: Rok Krulec, et al.
Published: (2003-11-01)

SMAC方法之應用於水躍模擬
by: WANG,JUN-JIE, et al.
Published: (1991)

AZD9291-induced Acute Interstitial Lung Disease
by: Ke-Ke Nie, et al.
Published: (2016-01-01)

In vitro demonstration of a potential role for STING agonist in HIV cure
by: A. Koblansky, et al.
Published: (2019-12-01)

Smac–Fdi: A Single Model Active Fault Detection and Isolation System for Unmanned Aircraft
by: Ducard Guillaume J.J.
Published: (2015-03-01)

BAX and SMAC regulate bistable properties of the apoptotic caspase system
by: Stephanie McKenna, et al.
Published: (2021-02-01)

The energy-efficient MDA-SMAC protocol for wireless sensor networks
by: Ke Wang, et al.
Published: (2020-01-01)

Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
by: Xiao-Yun Zhao, et al.
Published: (2020-04-01)

Molecular characterisation of the pro-apoptotic molecules APAF1 and Smac
by: Roberts, Darren Leslie
Published: (2001)

Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia
by: Chelsea N. Zimmerman, et al.
Published: (2017-06-01)

Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
by: Kate Welsh, et al.
Published: (2016-01-01)

Seasonality, mediation and comparison (SMAC) methods to identify influences on lung function decline
by: Emrah Gecili, et al.
Published: (2021-01-01)

AZD5363 inhibits inflammatory synergy between interleukin-17 and insulin/insulin-like growth factor 1
by: Chong eChen, et al.
Published: (2014-12-01)

High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
by: Maldonado Vilma, et al.
Published: (2006-10-01)

Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl‐1 Inhibitor AZD5991
by: Ardeshir Goliaei, et al.
Published: (2020-10-01)